Nov. 13 at 11:20 AM
$TVRD appears to be scheduled to release earnings today.
In Investor tab once at http://tvarditherspeautics.com for event-presentations there is a link to register to listen to a webcast. Tvardi Therapeutics is presenting on Jeffries Global Health Conference in London.
I am cautiously optimistic that
$TVRD will go up in the next few months if positive developments are noted in their clinical trials.
I am more focused on TTI-101 which is listed in Phase 1. The website reads “Human studies have shown that TTI-101 has the potential to benefit patients with conditions where STAT3 plays a central role, including cancer and IPF. TTI-101 is a pill taken by mouth twice daily.
Last stock price shown is
$4.24 and will see how this plays out later today and tomorrow and how the sentiment is moving next week. I would like to see
$TVRD be in the
$6-
$7 range within the next few days.
